Catherine Bollard, MD, associate center director for translational research and innovation at GW Cancer Center, was quoted by Interesting Engineering in an article about her recent study looking at the safety of a cell therapy involving expanding T-cells against HIV.
Interesting Engineering - First Ever HIV Immunotherapy Drug Proven Safe For Use in Humans
Latest News
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the appointment of Lorenzo Norris, MD, FACP, to a new leadership role, Senior Associate Dean for Education, effective Jan. 5, 2026.
The GW School of Medicine and Health Sciences and the GW Medical Faculty Associates are pleased to announce that Daniel Stein, MD, MHS, FACS, will serve as Chair of the Department of Urology. Stein has served as Interim Chair since May 2023 and has provided steady leadership during a period of…
Four members of the GW School of Medicine and Health Sciences MD program Class of 2026 received their residency match placements on Dec. 10, as part of this year’s Military Match.